Acuta Capital Partners, LLC Argenx Se Transaction History

Acuta Capital Partners, LLC

$52.7 Million
Q1 2025

A detailed history of Acuta Capital Partners, LLC transactions in Argenx Se stock. As of the latest transaction made, Acuta Capital Partners, LLC holds 7,023 shares of ARGX stock, worth $4.48 Million. This represents 7.88% of its overall portfolio holdings.

Number of Shares

7,023

Previous 6,910 1.64%

Holding current value

$4.48 Million

Previous $4.25 Million 2.19%

% of portfolio

7.88%

Previous 6.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$571.0 - $671.75 $64,523 - $75,907	113 Added 1.64%	7,023 $4.16 Million
Q4 2024 Feb 14, 2025	BUY	$520.52 - $638.33 $525,725 - $644,713	1,010 Added 17.12%	6,910 $4.25 Million
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $825,018 - $1.05 Million	1,900 Added 47.5%	5,900 $3.2 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $1.42 Million - $1.81 Million	4,000 New	4,000 $1.72 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $813,384 - $1.21 Million	2,400 New	2,400 $913,000
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $1.07 Million - $1.26 Million	2,974 Added 31.0%	12,568 $4.9 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $1.5 Million - $1.81 Million	4,494 Added 88.12%	9,594 $3.57 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $1.75 Million - $2.05 Million	5,100 New	5,100 $1.93 Million
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $2.4 Million - $3.69 Million	-22,500 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$113.31 - $150.51 $6.63 Million - $8.8 Million	-58,500 Reduced 72.22%	22,500 $2.56 Million
Q2 2019 Aug 14, 2019	BUY	$115.0 - $141.58 $2.01 Million - $2.48 Million	17,500 Added 27.56%	81,000 $11.5 Million
Q1 2019 May 14, 2019	BUY	$98.85 - $134.59 $1.04 Million - $1.41 Million	10,500 Added 19.81%	63,500 $7.93 Million
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $3.32 Million - $5.71 Million	-52,000 Reduced 49.52%	53,000 $5.09 Million
Q3 2018 Nov 07, 2018	SELL	$75.5 - $96.63 $26.3 Million - $33.6 Million	-348,233 Reduced 76.83%	105,000 $7.96 Million
Q2 2018 Aug 15, 2018	BUY	$74.84 - $100.16 $3.7 Million - $4.95 Million	49,412 Added 12.24%	453,233 $37.6 Million
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $4.6 Million - $6.89 Million	80,821 Added 25.02%	403,821 $32.5 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $2.41 Million - $6.78 Million	106,745 Added 49.36%	323,000 $20.4 Million
Q3 2017 Nov 14, 2017	BUY	$19.81 - $22.61 $4.28 Million - $4.89 Million	216,255	216,255 $4.89 Million

Others Institutions Holding ARGX

# of Institutions

498

Shares Held

28.6M

Call Options Held

331K

Put Options Held

226K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $35.3B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Account

Acuta Capital Partners, LLC Argenx Se Transaction History